financetom
Business
financetom
/
Business
/
Mastercard Insider Sold Shares Worth $10,202,458, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mastercard Insider Sold Shares Worth $10,202,458, According to a Recent SEC Filing
Sep 3, 2025 1:48 PM

04:20 PM EDT, 09/03/2025 (MT Newswires) -- Sachin J. Mehra, Chief Financial Officer, on September 02, 2025, sold 17,263 shares in Mastercard ( MA ) for $10,202,458. Following the Form 4 filing with the SEC, Mehra has control over a total of 31,234 Class A common shares of the company, with 31,234 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1141391/000114139125000184/xslF345X05/wk-form4_1756930391.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Commerical Space Company Momentus' Stock Down?
Why Is Commerical Space Company Momentus' Stock Down?
Sep 27, 2024
In-space infrastructure company, Momentus Inc. ( MNTS ) , shares are trading lower Friday after the company received a non-compliance notice from the Listing Qualifications Department indicating Momentus’ continued non-compliance with the minimum bid price requirement. The company also announced a U.S. district court has issued a preliminary order providing for approval of a derivative settlement. The Details: In addition...
BRIEF-Blank Check Company Newbury Street Ii Acquisition Corp Sees IPO Of $150 Million- SEC Filing
BRIEF-Blank Check Company Newbury Street Ii Acquisition Corp Sees IPO Of $150 Million- SEC Filing
Sep 27, 2024
* BLANK CHECK COMPANY NEWBURY STREET II ACQUISITION CORP SEES IPO OF $150 MILLION- SEC FILING Source text for Eikon: Further company coverage: [ ] ...
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
Bristol-Myers Squibb Gets FDA Approval for Schizophrenia Drug
Sep 27, 2024
09:28 AM EDT, 09/27/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) shares rose early Friday as the biopharmaceutical company obtained approval from the US Food and Drug Administration for its Cobenfy drug to treat schizophrenia in adults. The oral medication is designed to treat schizophrenia by targeting cholinergic receptors instead of dopamine receptors, which has traditionally been the standard...
Gryphon Digital Mining CFO Sim Salzman to Continue Role
Gryphon Digital Mining CFO Sim Salzman to Continue Role
Sep 27, 2024
09:48 AM EDT, 09/27/2024 (MT Newswires) -- Gryphon Digital Mining ( GRYP ) said Friday that its chief financial officer, Sim Salzman, will remain in his role and will not step down. The bitcoin mining firm said last month that Salzman will be stepping down from his position, effective Nov. 15. Price: 0.59, Change: -0.02, Percent Change: -3.59 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved